DUSP22 and mature T-cell and NK-cell non-Hodgkin lymphoma: Genome-wide massive parallel sequencing approaches will determine which molecular alterations coexist with DUSP22 inactivation in PTCL and may account for the favorable outcome of 6p25.3 rearranged tumors.